Stay informed with the latest pharma market trends and insights, covering emerging technologies, regulatory developments, market analysis, industry innovations, investment opportunities, and evolving healthcare landscapes. Explore expert perspectives on pharmaceutical research, drug development, biotechnology, clinical trials, and global market dynamics to make informed business and research decisions.
Artificial intelligence (AI) is revolutionizing the pharmaceutical industry by transforming how companies collect, analyze, and apply data to make smarter business and clinical decisions. From accelerating drug discovery to improving market research and forecasting healthcare trends, AI in pharmaceutical insights has become an essential tool for organizations looking to innovate and remain competitive. The harder […]
Analytics, decision science, and intelligence have become essential capabilities for pharmaceutical organizations seeking to compete in an increasingly complex pharma landscape. Every day, companies generate enormous amounts of information from clinical trials, commercial activities, real-world evidence, healthcare professionals, patient engagement, digital health platforms, and competitive intelligence. The challenge is no longer collecting data, it is […]
Market research and insights are at the heart of successful pharmaceutical decision-making. Every stage of the product lifecycle, from early development to commercialization and lifecycle management, depends on accurate, timely, and actionable intelligence. As healthcare becomes more data driven and patient focused, pharmaceutical organizations need professionals who can transform complex information into strategies that improve […]
The Executive Pharma Insights Conference (EPIC) is designed for professionals who are shaping the future of pharmaceutical market research, commercial strategy, analytics, artificial intelligence, market access, and innovation. As the pharmaceutical industry becomes increasingly data-driven, organizations need experts who can transform information into smarter business decisions. EPIC brings together leaders from across the life sciences […]
Artificial intelligence (AI) is transforming every aspect of the pharmaceutical industry, from drug discovery and clinical development to market research and commercial strategy. Many organizations have successfully launched AI pilot projects, demonstrating promising results in data analysis, automation, and decision support. Some teams are now looking at agentic AI for launch planning as the next […]
Semaglutide patent expiration is set to change the face of obesity and metabolic disease, bringing new opportunities and challenges for pharmaceutical companies, healthcare providers, and market researchers. As intellectual property protection evolves and competition intensifies, insights leaders will need to re-evaluate commercial assumptions, patient behaviour, pricing dynamics, and competitive positioning. The pace of innovation with […]
Policy intelligence is becoming a strategic capability for pharmaceutical organizations as regulatory requirements, healthcare policies, and market access frameworks continue to evolve. Pharmaceutical companies can no longer rely solely on clinical data and commercial insights when making business decisions. Changes in reimbursement policies, healthcare legislation, pricing frameworks, and regulatory guidance now influence product development, launch […]
Real-world data (RWD) platforms are becoming essential tools for pharmaceutical organizations seeking faster, more accurate, and evidence-based decision-making. As healthcare data volumes continue to grow, these platforms are evolving beyond simple data repositories into intelligent ecosystems that combine artificial intelligence, advanced analytics, and integrated data sources — the mix insights teams now treat as their […]
Patient-centric insights are transforming how pharmaceutical companies develop therapies, design clinical trials, and deliver healthcare solutions. While collecting patient data has become easier than ever through digital technologies and healthcare systems, the real challenge lies in converting that information into actionable strategies that improve patient outcomes and business performance. Today’s pharmaceutical organizations are shifting from […]
Real-world evidence (RWE) is now among the most valuable assets in pharma strategy. Clinical trials are the gold standard for proving safety and efficacy, but they cannot answer all commercial, clinical or market access questions. Traditional research is supplemented by real-world evidence, which offers insights into how therapies perform in everyday clinical practice, helping pharma […]